UBS lowered the firm’s price target on Ovintiv (OVV) to $56 from $59 and keeps a Buy rating on the shares. The firm sees “a mixed outlook for Energy in 2025,” noting on the positive side that it sees natural gas momentum building, but adding that crude oil prices face downward pressure and “attractive valuations may not be enough to bring in new investors.”